Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Second Affiliated Hospital, Zhejiang University, School of Medicine
With
OmixScience Institute
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Patients ≥18 years old and ≤70 years old;
2. Plasma of the participant can be obtained;
3. Willing to sign the informed consent;
4. Meet one of the following criteria:
4.1)Patients diagnosed with invasive breast cancer or carcinoma in situ of the breast for the first time; 4.2)Patients with breast fibroma or breast adenosis and breast fibrocystic hyperplasia;
You may not be if
In any of the following situations, subjects should not participate in the trial:
1. Pregnant or lactating;
2. Unable to obtain the participant's plasma;
3. Patients with other types of malignant tumors diagnosed by pathology within 5 years before enrollment;
4. The patients had suspected imaging (B-ultrasound, CT, etc.) of other malignant tumors within the past 1 year after enrollment, but no pathological confirmation;
5. Received any blood product transfusion in the past 30 days;
6. Participants considered by the investigator to be inappropriate to participate in this research-type clinical trial.
Clareo Health | Exploring a Breast Cancer Early Screening Model Based on cfDNA
